Try our Advanced Search for more refined results

PELLETIER v. ENDO INTERNATIONAL PLC et al

  1. October 15, 2021

    Endo Investors Ink $63M Deal In Generics Stock Inflation Suit

    Endo International and a class of investors told a Pennsylvania federal court Friday that they reached a $63.4 million settlement to resolve claims Endo inflated its stock price by hiking its generic drug prices in tandem with competitors and then lied to investors about how it had increased its profits.

  2. June 24, 2021

    Endo Wants Out Of Investors' Stock Inflation Suit

    Endo International PLC sought to squash investors' claims it had artificially inflated its stock prices by hiking its generic drug prices in tandem with competitors, telling a Pennsylvania federal judge that none of the statements the plaintiffs pointed to were false, misleading or actionable.

  3. May 21, 2021

    Endo Investors Win Operatic Class Cert. In Generic Price Suit

    A Pennsylvania federal judge on Thursday certified a class of investors accusing Endo International PLC of artificially inflating its stock price, likening the impact of the pharmaceutical company's alleged misrepresentations to King Philip's multilayered betrayal in Giuseppe Verdi's "Don Carlo."

  4. February 19, 2021

    Bleichmar Fonti Wants To Retake Lead In Endo Investor Suit

    A Chicago-based retirement fund and attorneys from Bleichmar Fonti & Auld asked a federal judge to reinstate them as leads in a stockholder class action against Endo Pharmaceuticals, arguing that the court erred in ruling that buying Endo stock 97 seconds after news broke of an alleged price-fixing scheme had raised issues disqualifying them.

  5. February 05, 2021

    Lead Plaintiff Booted From Endo Suit Over 97-Second Lag

    Bleichmar Fonti & Auld LLP is out as lead plaintiffs' counsel in an Endo Pharmaceuticals stockholder class action, replaced by Saxton & Stump LLC, after a Pennsylvania federal judge found out that the previous lead plaintiff bought shares 97 seconds after news broke of the alleged price-fixing scheme.

  6. January 19, 2021

    Lead Plaintiff In Endo Investors' Suit Slams Other Bids

    A retirement fund leading a proposed class action accusing drugmaker Endo International of artificially inflating its stock price is fighting to remain as the lead plaintiff and urged a Pennsylvania federal judge Monday to reject competing bids to replace the fund.

  7. January 08, 2021

    Pomerantz Asks To Take Lead Of Endo Investors' Suit

    Pomerantz LLP asked a Pennsylvania federal judge Thursday to appoint it the new lead counsel in a proposed securities class action accusing Endo International PLC of artificially inflating its stock price, after the court highlighted issues with the Chicago pension fund currently serving as lead plaintiff.

  8. August 18, 2020

    Endo Fights Class Cert. In Investors' Drug Price-Fixing Suit

    Endo International challenged its shareholders' class certification bid in their generic drug price-fixing suit, arguing in Pennsylvania federal court that the Chicago pension fund seeking to represent the class fails to satisfy several of the federal requirements for the role.

  9. June 29, 2020

    Endo Investors Seek Cert. After Losing Price-Fixing Claims

    Endo International investors want a Pennsylvania federal judge to sign off on their bid to become a full-fledged class action, telling the court their claims the drugmaker artificially inflated stock prices are perfectly suited for the legal vehicle.

  10. February 14, 2020

    Endo Shareholders' Price-Fixing Claims Can't Sway Judge

    A Pennsylvania federal judge ruled Friday that investors in a would-be class action against Endo International PLC had failed to bring forward sufficient evidence to support their claim that the pharmaceutical company conspired with competitors to fix prices for generic drugs.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!